Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Penn Medicine Amyloidosis Program
3400 Spruce StreetPhiladelphia, Pennsylvania, United States
Phone Web
The Amyloidosis Program at Penn Medicine is involved in the treatment and diagnosis of amyloidosis and the development of new drugs to treat the disease and its variants. Amyloidosis can have a variety of causes, and as a result, the Program brings together specialists from cardiology, nephrology, hematology-oncology, neurology, rheumatology, pulmonology and organ transplantation.
The team includes healthcare professionals in the following areas:
Hematology and Oncology:
Adam D. Cohen, MD
Cardiology:
Hansie M. Mathelier, MD, FACC
Neurology:
Sami L. Khella, MD; Chafic Karam, MD
Nephrology:
Laura M. Dember, MD
Related Content
-
University of Utah Health, Amyloidosis ProgramAmyloidosis is a complicated disorder th...
-
The Peripheral Nerve Center at Johns HopkinsThe Peripheral Nerve Center at Johns Hop...
-
NYU Langone Amyloidosis ProgramWe provide the expert, multidisciplinary...
-
Amyloidose-Zentrum – Universitätsklinikum HeidelbergThe Amyloidose-Zentrum was founded at th...
-
University of Miami Health System, Sylvester Comprehensive Cancer CenterAmyloidosis is a rare protein depositi...
-
Michelle Kaku, MDDr. Michelle Kaku, MD is an Assistant Pr...
-
University of Rochester Medical Center Comprehensive Amyloidosis ProgramThe University of Rochester Medical Cent...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.